drugset / Trial / NCT00603993
Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety of subcutaneous (SC) self-injections (by the subject or subject's family member) of adalimumab in adult Japanese subjects with Rheumatoid Arthritis in an open-label study.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Subject | Adalimumab | Monoclonal antibody | 80 mg | Subcutaneous |